Genmab reported DKK0 in Stock for its fourth fiscal quarter of 2020.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alexion Pharmaceuticals ALXN:US $ 803.9M 28.2M
Almirall ALM:SM 130.92M 1.48M
Amgen AMGN:US $ 4115M 98M
Argen X Bv ARGX:BB 59.22M 38.68M
Bayer BAYN:GR € 10125M 332M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Bluebird Bio BLUE:US $ 13.5M 4.58M
Exelixis EXEL:US $ 24.98M 0.22M
GlaxoSmithKline GSK:LN 6330M 114M
GN Store Nord GN:DC DK 1724M 108M
GRIFOLS GRF:SM € 2124.39M 13.61M
H. Lundbeck A/S LUN:DC 2.6B 14M
Hikma Pharmaceutical HIK:LN 736M 21M
Merck MRK:GR € 3564M 102M
Novartis NOVN:VX SF 7111M 114M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
William Demant Holding WDH:DC 2.09B 120M